GSK to buy phase III-ready drug efimosfermin from Boston Pharmaceuticals for as much as $2B GSK to buy phase III-ready drug efimosfermin from Boston Pharmaceuticals for as much as $2B Post ContentgskRead More You might also be interested in reading Search for British hiker missing in New Zealand ‘paused’. May 14, 2025 In Mainstream ← Previous post Next post →